(RO) Roche Holding - Performance 17.5% in 12m
Compare RO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-1.89%
#60 in Group
Rel. Strength
75.43%
#1963 in Universe
Total Return 12m
17.49%
#37 in Group
Total Return 5y
-5.06%
#66 in Group
P/E 28.6
70th Percentile in Group
P/E Forward 14.3
50th Percentile in Group
PEG 0.72
40th Percentile in Group
FCF Yield 7.30%
75th Percentile in Group
12m Total Return: RO (17.5%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: RO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RO
Total Return (including Dividends) | RO | XLV | S&P 500 |
---|---|---|---|
1 Month | -14.66% | -7.37% | -5.89% |
3 Months | -3.60% | -4.55% | -12.45% |
12 Months | 17.49% | -0.54% | 6.72% |
5 Years | -5.06% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | RO | XLV | S&P 500 |
1 Month | -83.4% | -82.6% | -74.5% |
3 Months | 4.0% | -37.8% | -88.2% |
12 Months | 53.9% | -1.6% | 66.1% |
5 Years | -30.8% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #115 | -7.87% | -9.32% |
3 Month | #54 | 1.0% | 10.1% |
12 Month | #37 | 18.1% | 10.1% |
5 Years | #67 | -35.2% | -52.8% |
FAQs
Does RO Roche Holding outperforms the market?
Yes,
over the last 12 months RO made 17.49%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months RO made -3.60%, while XLV made -4.55%.
Over the last 3 months RO made -3.60%, while XLV made -4.55%.
Performance Comparison RO vs Indeces and Sectors
RO vs. Indices RO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 6.15% | -8.77% | 2.18% | 10.8% |
US NASDAQ 100 | QQQ | 7.01% | -8.38% | 2.71% | 12.0% |
US Dow Jones Industrial 30 | DIA | 7.32% | -8.84% | 1.64% | 12.2% |
German DAX 40 | DAX | 0.79% | -5.26% | -14.9% | -0.72% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.44% | -7.16% | -0.10% | 11.6% |
Hongkong Hang Seng | HSI | 1.86% | -4.84% | 0.66% | 1.27% |
India NIFTY 50 | INDA | 1.78% | -19.4% | -0.27% | 14.4% |
Brasil Bovespa | EWZ | 2.59% | -9.58% | -0.77% | 27.0% |
RO vs. Sectors RO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 5.90% | -9.0% | -6.63% | 3.95% |
Consumer Discretionary | XLY | 7.02% | -10.7% | -0.56% | 8.27% |
Consumer Staples | XLP | 2.85% | -17.9% | -8.04% | 3.55% |
Energy | XLE | 1.43% | -4.58% | 1.12% | 27.8% |
Financial | XLF | 4.78% | -10.2% | -5.94% | -1.46% |
Health Care | XLV | 5.75% | -7.29% | 3.58% | 18.0% |
Industrial | XLI | 5.03% | -9.96% | 2.10% | 12.1% |
Materials | XLB | 4.43% | -8.01% | 9.26% | 25.0% |
Real Estate | XLRE | 0.81% | -11.8% | 0.83% | 0.38% |
Technology | XLK | 7.51% | -5.73% | 8.99% | 18.7% |
Utilities | XLU | 2.84% | -14.2% | -3.56% | -6.88% |
Aerospace & Defense | XAR | 4.46% | -14.7% | -7.58% | -6.67% |
Biotech | XBI | 2.59% | -2.78% | 16.7% | 26.4% |
Homebuilder | XHB | 5.20% | -7.82% | 20.1% | 26.6% |
Retail | XRT | 4.45% | -12.6% | 6.85% | 21.9% |